US5114719A
(en)
*
|
1987-04-29 |
1992-05-19 |
Sabel Bernhard A |
Extended drug delivery of small, water-soluble molecules
|
US5156164A
(en)
*
|
1988-10-13 |
1992-10-20 |
Leveen Harry H |
Iodine contraceptive sponge
|
BE1002600A3
(fr)
*
|
1988-11-23 |
1991-04-09 |
Wildemeersch Dirk |
Dispositif intra-uterin perfectionne.
|
IE71202B1
(en)
*
|
1990-12-17 |
1997-02-12 |
Akzo Nv |
Progestagen-only contraceptive
|
WO1993017662A1
(en)
*
|
1992-03-02 |
1993-09-16 |
Daratech Pty. Ltd. |
Improved implants
|
ES2150427T3
(es)
*
|
1992-06-02 |
2000-12-01 |
Bard Inc C R |
Procedimiento y dispositivo de implante para el suministro de farmacos a largo plazo.
|
US5368588A
(en)
*
|
1993-02-26 |
1994-11-29 |
Bettinger; David S. |
Parenteral fluid medication reservoir pump
|
US5443461A
(en)
*
|
1993-08-31 |
1995-08-22 |
Alza Corporation |
Segmented device for simultaneous delivery of multiple beneficial agents
|
US5681817A
(en)
|
1994-02-04 |
1997-10-28 |
The Medical College Of Hampton Roads |
Treatment of ovarian estrogen dependent conditions
|
US5660848A
(en)
*
|
1994-11-02 |
1997-08-26 |
The Population Council, Center For Biomedical Research |
Subdermally implantable device
|
US5521166A
(en)
*
|
1994-12-19 |
1996-05-28 |
Ortho Pharmaceitical Corporation |
Antiprogestin cyclophasic hormonal regimen
|
DE19539361A1
(de)
*
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
|
US5733565A
(en)
*
|
1996-02-23 |
1998-03-31 |
The Population Council, Center For Biomedical Research |
Male contraceptive implant
|
CN1088993C
(zh)
*
|
1996-10-11 |
2002-08-14 |
上海市计划生育科学研究所 |
含孕二烯酮的长效皮下避孕埋植剂
|
US6203813B1
(en)
|
1997-01-13 |
2001-03-20 |
Lance L. Gooberman |
Pharmaceutical delivery device and method of preparation therefor
|
IL123813A0
(en)
*
|
1997-04-11 |
1998-10-30 |
Akzo Nobel Nv |
Drug delivery system for two or more active substances
|
DE19744135C1
(de)
*
|
1997-09-29 |
1999-03-25 |
Schering Ag |
Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
|
AU748653B2
(en)
|
1998-05-01 |
2002-06-06 |
John F. Cline |
Method for injection molding manufacture of controlled release devices
|
US6117441A
(en)
*
|
1998-07-02 |
2000-09-12 |
The Population Council, Inc. |
Silicone core long term androgen delivery implant
|
EP1098653A2
(en)
*
|
1998-07-17 |
2001-05-16 |
PHARMACIA & UPJOHN COMPANY |
Subcutaneous medroxyprogesterone acetate for contraception
|
US6063395A
(en)
*
|
1998-11-12 |
2000-05-16 |
Leiras Oy |
Drug delivery device especially for the delivery of progestins and estrogens
|
US6117442A
(en)
*
|
1998-11-12 |
2000-09-12 |
Leiras Oy |
Drug delivery device, especially for the delivery of androgens
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
CA2267743C
(en)
*
|
1999-03-30 |
2011-07-26 |
Robert F. Casper |
Low dose estrogen interrupted hormone replacement therapy
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
AU2001291775B2
(en)
*
|
2000-08-23 |
2005-09-08 |
N.V. Organon |
Testosterone ester formulation for human use
|
JP2006500115A
(ja)
|
2000-11-16 |
2006-01-05 |
マイクロスフエリツクス・エル・エル・シー |
密封小線源治療用の可撓性および/または弾性シードまたはストランド
|
JP4866535B2
(ja)
|
2001-05-11 |
2012-02-01 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
動物で用いるに適した免疫調節用デバイス
|
CA2452606C
(en)
|
2001-07-02 |
2011-09-13 |
Akzo Nobel N.V. |
Tetrahydroquinoline derivatives
|
AU2002313517B2
(en)
*
|
2001-08-31 |
2007-09-06 |
Bayer Schering Pharma Oy |
Drug delivery system
|
CN1261437C
(zh)
|
2001-09-04 |
2006-06-28 |
阿克佐诺贝尔公司 |
具有LH与FSH联合激动活性的甘氨酸-取代的噻吩并[2,3-d]嘧啶
|
TWI228508B
(en)
|
2001-09-04 |
2005-03-01 |
Akzo Nobel Nv |
Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity
|
JP2005522418A
(ja)
*
|
2002-01-24 |
2005-07-28 |
スマート ドラッグ システムズ インコーポレイティド |
徐放性医薬組成物
|
JP2005519964A
(ja)
*
|
2002-03-11 |
2005-07-07 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
スルファターゼ阻害プロゲストゲンのみの避妊レジメン
|
TWI297685B
(en)
|
2002-04-04 |
2008-06-11 |
Organon Nv |
Non-steroidal progesterone receptor modulators
|
CN1658836A
(zh)
*
|
2002-05-07 |
2005-08-24 |
控制传输系统公司 |
形成药物传递装置的方法
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
EP1509182A4
(en)
*
|
2002-05-31 |
2009-12-30 |
Titan Pharmaceuticals Inc |
IMPLANTABLE POLYMERS DEVICE FOR THE DELAYED RELEASE OF BUPRENORPHINE
|
KR20050059092A
(ko)
*
|
2002-08-28 |
2005-06-17 |
로버트 캐스퍼 |
에스트로겐 보충 요법
|
KR20050072812A
(ko)
|
2002-11-07 |
2005-07-12 |
악조 노벨 엔.브이. |
안드로겐-수용체와 관련된 질병의 치료에 효과적인 인돌
|
TWI322012B
(en)
|
2002-12-20 |
2010-03-21 |
Organon Nv |
Tetrahydroquinoline derivatives
|
TWI306855B
(en)
|
2002-12-20 |
2009-03-01 |
Organon Nv |
Tetrahydroquinoline derivatives
|
CN1777426A
(zh)
*
|
2003-03-31 |
2006-05-24 |
泰坦医药品公司 |
用于持续释放多巴胺受体激动剂的可植入聚合物装置
|
WO2004096151A2
(en)
|
2003-04-29 |
2004-11-11 |
The General Hospital Corporation |
Methods and devices for the sustained release of multiple drugs
|
TWI336627B
(en)
|
2003-05-23 |
2011-02-01 |
Organon Nv |
Drug delivery system,and use and manufacturing method thereof
|
US20050031668A1
(en)
*
|
2003-05-30 |
2005-02-10 |
Patel Rajesh A. |
Implantable polymeric device for sustained release of nalmefene
|
US20070259014A1
(en)
*
|
2003-06-20 |
2007-11-08 |
Vgx Pharmaceuticals, Inc. |
Compositions for and Methods for Treating Hiv
|
JP2007517913A
(ja)
*
|
2004-01-13 |
2007-07-05 |
バソジェニックス ファーマシューティカルズ, インコーポレイテッド |
カルシトニン遺伝子関連ペプチドを投与することによって急性心筋梗塞を処置するための方法およびカルシトニン遺伝子関連ペプチドを含有する組成物
|
EP1703915A2
(en)
*
|
2004-01-13 |
2006-09-27 |
Vasogenix Pharmaceuticals, Inc. |
Methods of using cgrp for cardiovascular and renal indications
|
CA2552677A1
(en)
*
|
2004-01-13 |
2005-07-28 |
Vasogenix Pharmaceuticals, Inc. |
Controlled release cgrp delivery composition for cardiovascular and renal indications
|
TWI434676B
(zh)
|
2004-03-19 |
2014-04-21 |
Merck Sharp & Dohme |
可用x射線看出之藥物遞送裝置
|
TW200531977A
(en)
|
2004-03-25 |
2005-10-01 |
Akzo Nobel Nv |
Progesterone receptor modulators
|
TW200602317A
(en)
|
2004-04-23 |
2006-01-16 |
Akzo Nobel Nv |
Novel androgens
|
DE602004008912T3
(de)
|
2004-07-13 |
2012-09-13 |
Bayer Schering Pharma Oy |
Retardiertes Freigabesystem mit kontrollierter Initialabgabe
|
AU2005325213B2
(en)
|
2004-08-04 |
2010-10-07 |
Evonik Corporation |
Methods for manufacturing delivery devices and devices thereof
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
EP1896017A2
(en)
|
2005-06-15 |
2008-03-12 |
Hydra Biosciences, Inc. |
Modulators of sperm hypermotility and uses thereof
|
EP1743638A1
(en)
|
2005-07-15 |
2007-01-17 |
Laboratorios Del Dr. Esteve, S.A. |
Pharmaceutical formulations of substituted pyrazoline compounds
|
PL2359808T3
(pl)
|
2006-08-09 |
2013-10-31 |
Intarcia Therapeutics Inc |
Osmotyczne systemy dostawcze i zespoły tłokowe
|
US7989442B2
(en)
|
2006-09-27 |
2011-08-02 |
N.V. Organon |
Progesterone receptor modulators
|
CN101209238B
(zh)
*
|
2006-12-27 |
2012-05-09 |
辽宁省计划生育科学研究院 |
含孕二烯酮的生物降解型长效皮下避孕埋植剂及其制备
|
CA2683610C
(en)
|
2007-04-23 |
2013-01-08 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
US8063037B2
(en)
|
2007-05-07 |
2011-11-22 |
N. V. Organon |
Progesterone receptor modulators
|
CN101130057B
(zh)
*
|
2007-07-06 |
2011-04-27 |
复旦大学 |
胸腺五肽长效植入剂及其制备方法
|
US8741329B2
(en)
|
2007-09-21 |
2014-06-03 |
Merck Sharp & Dohme B.V. |
Drug delivery system
|
EP2227252B1
(en)
|
2007-11-27 |
2012-07-25 |
Nira Hochman |
Adjuvant comprising vaccinium macrocarpon
|
JP5502751B2
(ja)
|
2007-12-20 |
2014-05-28 |
エボニック コーポレイション |
低残留溶媒濃度を有する微粒子を調製するためのプロセス
|
DK2240155T3
(da)
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
|
KR101823699B1
(ko)
|
2009-09-28 |
2018-01-30 |
인타르시아 세라퓨틱스 인코포레이티드 |
실질 항정상태 약물 전달의 신속 확립 및/또는 종결
|
CN102740830A
(zh)
*
|
2009-12-23 |
2012-10-17 |
普西维达公司 |
缓释递送装置
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US10028858B2
(en)
|
2011-07-11 |
2018-07-24 |
Medicines360 |
Intrauterine systems, IUD insertion devices, and related methods and kits therefor
|
AR089765A1
(es)
*
|
2012-01-23 |
2014-09-17 |
Bayer Oy |
Un sistema para el suministro de un farmaco
|
AU2014214537B2
(en)
|
2013-02-06 |
2019-01-03 |
Mark SILLENDER |
Therapeutic substance transfer catheter and method
|
AU2014214538B2
(en)
|
2013-02-06 |
2018-11-15 |
Mark SILLENDER |
Embryo transfer catheter and method
|
US10413504B2
(en)
|
2013-12-11 |
2019-09-17 |
Merck Sharp & Dohme Corp. |
Intravaginal ring drug delivery system
|
US10596103B2
(en)
|
2013-12-11 |
2020-03-24 |
Merek Sharp & Dohme B.V. |
Drug delivery system for delivery of anti-virals
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
WO2016149561A1
(en)
*
|
2015-03-17 |
2016-09-22 |
Oak Crest Institute Of Science |
Subdermal implants for the sustained delivery of water-soluble drugs
|
MX2017015504A
(es)
|
2015-06-03 |
2018-05-15 |
Intarcia Therapeutics Inc |
Sistemas de colocacion y remoción de implante.
|
AU2017268161B2
(en)
|
2016-05-16 |
2020-03-12 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
US10188602B2
(en)
|
2016-09-29 |
2019-01-29 |
Gesea Biosciences Inc. |
Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
|
AU2018206539A1
(en)
|
2017-01-03 |
2019-07-18 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
US11571328B2
(en)
|
2018-04-09 |
2023-02-07 |
Medicines360 |
IUD insertion devices
|
EP3801462A4
(en)
*
|
2018-05-24 |
2022-03-16 |
Celanese EVA Performance Polymers LLC |
IMPLANTABLE DEVICE FOR EXTENDED RELEASE OF A MACROMOLECULAR DRUG COMPOUND
|
MX2020012459A
(es)
*
|
2018-05-24 |
2021-04-28 |
Celanese Eva Performance Polymers Llc |
Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
|
US20200261258A1
(en)
|
2019-02-19 |
2020-08-20 |
Medicines360 |
Devices, systems, methods and kits for insertion and removal of iuds
|
BR102020007749A2
(pt)
|
2020-04-17 |
2021-11-03 |
Edson Luiz Peracchi |
Implante subcutâneo reabsorvível de longa duração com liberação controlada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da endometriose
|
BR102020010923A2
(pt)
|
2020-05-29 |
2021-12-14 |
Luiz Peracchi Edson |
Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da insuficiência adrenal crônica ou hipocortisolismo
|
BR102020013862A2
(pt)
|
2020-07-07 |
2022-01-18 |
Edson Luiz Peracchi |
Implante subcutâneo reabsorvível de longa duração com liberação sustentada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da doença de parkinson
|
US20240165064A1
(en)
|
2021-03-29 |
2024-05-23 |
Edson Luiz Peracchi |
Long-lasting resorbable subcutaneous implant with prolonged release of pre-concentrated pharmacologically active substance in polymer for the treatment of hypothyroidism, and method
|
CN113209050A
(zh)
*
|
2021-05-14 |
2021-08-06 |
浙江恒冀制药有限责任公司 |
基于生物相容性聚合物的长效体内皮埋或内植缓释制剂
|
GB202401392D0
(en)
|
2024-02-02 |
2024-03-20 |
Imphatec Ltd |
Implant for delivery of a drug
|